3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
9
Myelodysplastic Syndromes
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Advanced Solid Neoplasm
2
Solid Tumors
1
Renal Insufficiency
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Liver Diseases
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Central Nervous System Neoplasms
1
Advanced Solid Tumors
1
Advanced Nonhematologic Malignancies
1
Interventions
Cyclophosphamide
52
Cytarabine
49
fludarabine phosphate
38
fludarabine
32
Filgrastim
30
Etoposide
23
Rituximab
19
Azacitidine
17
Whole-Body Irradiation
16
Tacrolimus
14
Peripheral Blood Stem Cell Transplantation
13
Granulocyte Colony-Stimulating Factor
13
Decitabine
13
Clofarabine
13
venetoclax
12
Melphalan
12
Antilymphocyte Serum
12
Mycophenolic Acid
11
Methotrexate
11
Radiotherapy
10
Mitoxantrone
10
Daunorubicin
10
Busulfan
10
sargramostim
9
aldesleukin
9
Vincristine
9
Sirolimus
9
Topotecan
8
Idarubicin
8
Dexamethasone
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Leukemia
×
pevonedistat
×
Clear all
NCT04172844
2024-06-04
PAVE
Medical College of Wisconsin
Phase 1
Terminated
16 enrolled